Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Symptomatic relief of cough and hay fever as well as reduction of bronchial and nasal congestion Clinical selection for Chlorpheniramine mal.2mg, ephedrine Hcl 5mg, menthol 0.25mg, sodium citrate 40mg/5ml should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
[From component Chlorpheniramine] Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.
Store as labelled. Keep out of reach of children.